Neuropharmacology

Cards (21)

  • One common class of drugs alters how neurotransmitters are cleared from the synaptic cleft
  • Serotonin Selective Reuptake Inhibitors (SSRIs) are drugs that inhibit the function of the reuptake transporter found in synapses that release the neurotransmitter serotonin
  • Reuptake transporters are proteins that bind to neurotransmitters and remove them from the synaptic cleft
  • Some examples of SSRIs are Prozac and Zoloft, which both treat mood disorders
  • Drugs usually impact neurotransmitters in one of two ways: as an agonist or antagonist
  • An agonist is a drug that enhances the activity of a neurotransmitter
  • Agonist drugs often mimic the action of the endogenous neurotransmitter it binds to
  • Endogenous means naturally occurring
  • Competitive agonists compete for the same binding site with the endogenous neurotransmitter
  • For competitive agonists to be effective, they usually need to be more concentrated than the endogenous neurotransmitter
  • Noncompetitive agonists are also called allosteric modulators
  • Noncompetitive agonists can increase the activity of the neurotransmitter without blocking its binding site
  • Partial agonists compete for the same binding site, but have a smaller physiological effect on the postsynaptic receptor than the usual neurotransmitter
  • An antagonist drug decreases or even fully blocks the activity of the neurotransmitter
  • Antagonist drugs work to prevent the binding or the action of the endogenous neurotransmitter
  • Competitive antagonists block the binding site of a receptor
  • Noncompetitive antagonists bind at a different site than the endogenous neurotransmitter, which in turn changes the shape of the receptor to decrease the effect of the usual neurotransmitter
  • An allosteric site is a site on a protein that can be modified by a second molecule (Where noncompetitive antagonists go)
  • L-DOPA is an agonist that is used to treat Parkinson's disease
  • Parkinson's disease involves the death of dopamine-producing neurons in the basal ganglia
  • L-DOPA increases the amount of dopamine in the neurons of the brain